Suven Life Sciences Limited (NSE:SUVEN)

Suven Life Sciences Statistics

Total Valuation

NSE:SUVEN has a market cap or net worth of INR 70.15 billion. The enterprise value is 65.14 billion.

Market Cap	70.15B
Enterprise Value	65.14B

Important Dates

The last earnings date was Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	263.72M
Shares Outstanding	n/a
Shares Change (YoY)	+4.47%
Shares Change (QoQ)	+0.77%
Owned by Insiders (%)	1.88%
Owned by Institutions (%)	2.94%
Float	75.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	333.33
PB Ratio	11.86
P/TBV Ratio	11.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.57
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.23

Financial Position

The company has a current ratio of 17.69, with a Debt / Equity ratio of 0.03.

Current Ratio	17.69
Quick Ratio	16.94
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.80% and return on invested capital (ROIC) is -423.42%.

Return on Equity (ROE)	-78.80%
Return on Assets (ROA)	-45.46%
Return on Invested Capital (ROIC)	-423.42%
Return on Capital Employed (ROCE)	-46.55%
Weighted Average Cost of Capital (WACC)	8.11%
Revenue Per Employee	1.52M
Profits Per Employee	-20.02M
Employee Count	138
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.60% in the last 52 weeks. The beta is 0.71, so NSE:SUVEN's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+25.60%
50-Day Moving Average	186.99
200-Day Moving Average	187.07
Relative Strength Index (RSI)	75.18
Average Volume (20 Days)	2,243,005

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SUVEN had revenue of INR 210.45 million and -2.76 billion in losses. Loss per share was -12.13.

Revenue	210.45M
Gross Profit	210.45M
Operating Income	-2.76B
Pretax Income	-2.76B
Net Income	-2.76B
EBITDA	-2.71B
EBIT	-2.76B
Loss Per Share	-12.13

Balance Sheet

The company has 5.18 billion in cash and 166.94 million in debt, with a net cash position of 5.01 billion.

Cash & Cash Equivalents	5.18B
Total Debt	166.94M
Net Cash	5.01B
Net Cash Per Share	n/a
Equity (Book Value)	5.91B
Book Value Per Share	26.20
Working Capital	5.16B

Cash Flow

In the last 12 months, operating cash flow was -3.02 billion and capital expenditures -50.83 million, giving a free cash flow of -3.07 billion.

Operating Cash Flow	-3.02B
Capital Expenditures	-50.83M
Depreciation & Amortization	56.14M
Net Borrowing	n/a
Free Cash Flow	-3.07B
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-1,312.37%
Pretax Margin	-1,313.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NSE:SUVEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.47%
Shareholder Yield	-4.47%
Earnings Yield	-3.94%
FCF Yield	-4.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3